Purpose: To describe findings in a patient with choroideremia (CHM) and his mother, an obligate CHM carrier.
C horoideremia (CHM) is an X-linked retinal dystrophy caused by loss-of-function mutations in Rab escort protein-1 (REP1), a gene product that facilitates vesicular trafficking. This rare disorder typically only affects men, who experience nyctalopia, loss of peripheral vision, and eventual blindness. 1 Characteristics of this disease are pigmentary changes and a progressive degeneration of photoreceptors, choriocapillaris, and the retinal pigment epithelium (RPE), which can lead to visibly bare sclera. 1 Female carriers of CHM are typically asymptomatic, although retinal findings may include patchy fundus pigmentation thought to be secondary to random X-chromosome inactivation. 1 We present a case of a patient with CHM and his mother who is an obligate carrier using multimodal imaging techniques, including optical coherence tomography (OCT) angiography.
Case Report
A 25-year-old African American man with night blindness and poor peripheral vision since childhood was referred to our clinic. His family history was notable for poor night vision in his maternal grandfather and maternal cousin. He experienced acute loss of vision in his left eye 15 years ago from a subretinal hemorrhage secondary to choroidal neovascularization, and on examination, (Figure 2 , D and G), which appeared to correspond to areas of RPE atrophy visible on fundus autofluorescence. Genetic analysis confirmed a diagnosis of CHM, and the patient was subsequently enrolled in the phase II clinical trial using adeno-associated viral vector-encoding REP1.
Given the patient's diagnosis of CHM, his 50-year-old mother was examined to determine the severity of her carrier state. She had no visual complaints and visual acuity was 20/20 in both eyes. Slit-lamp examination was unremarkable, but fundus examination revealed patchy peripheral pigmentary mottling with areas of hypopigmentation and pigment clumping in both eyes ( (Figures 4, D, E, G and H, yellow arrows) . Overall, the choriocapillaris was significantly more preserved in the mother than in her son; thus, the larger choroidal vessels were not as well visualized on OCT angiography. 
Discussion
Choroideremia is an X-linked retinal dystrophy characterized by progressive degeneration of the choroid and RPE in affected men, with milder phenotypes in carrier women. Although most women carriers exhibit no visual impairment, the severity of findings can vary greatly, with occasional cases of severe retinal abnormalities likely due to unbalanced X-chromosome inactivation. [2] [3] [4] The mosaic pattern seen on retinal examination and multifocal electroretinography testing, even in asymptomatic carriers, is also attributed to random X-chromosome inactivation early in development, where variable expression of the mutated REP1 protein leads to patches of normal and mutated cells. 5, 6 A clinical diagnosis of CHM can often be made on fundus examination, where yellowish-white sclera can be visible due to extensive RPE loss. As in our case, foveal thickening on OCT in young individuals with CHM is not uncommon. 7 Furthermore, it has previously been reported that OCT angiography can reveal more extensive damage to choriocapillaris blood flow in CHM than deep retinal flow, consistent with our results. 8 Findings in our CHM carrier were also consistent with cases previously reported. Renner et al 2 similarly described a case with peripheral pigmentary stippling with regions of hypopigmentation on fundus examination, corresponding hyperfluorescent specks on fundus autofluorescence, and subtle RPE irregularities on horizontal OCT scans through the macula. In particular, it is important for the clinician to distinguish these characteristic fundus findings in CHM carriers from other disease states that demonstrate salt-and-pepper retinopathy. Although X-linked CHM carriers have subretinal flecks in a reticular pattern, ocular albinism carriers tend to have pigment mottling in a radial pattern, X-linked carriers of retinitis pigmentosa demonstrate a characteristic tapetal reflex, and congenital rubella show pigment mottling in the macula.
Choroideremia carriers can progress slowly over time. A report of two female CHM carriers who were followed for 11 and 17 years demonstrated a slow progression of retinal and/or RPE abnormalities and the eventual development of subnormal 30-Hz flicker responses on full-field electroretinography. 2 As the female carrier in this case displayed subtle areas of flow loss in the choriocapillaris and choroid on OCT angiography, we suspect during long-term follow-up that further decrease in the choriocapillaris circulation may result. Thus, OCT angiography may be another means by which to further characterize and quantify the extent of dysfunction in the carrier state with the likelihood of other carriers demonstrating a spectrum of abnormalities on OCT angiography given the condition's variable presentation.
Considering the advancement of retinal imaging, modalities such as OCT angiography are being more frequently used to study retinal disease. Its use in CHM and its carrier state aids in the characterization of disease progression.
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